Alteration of gene expression of G protein-coupled receptors in endocrine disruptors-caused hyperactive rats

Masami Ishido1, Masatoshi Morita, Syuichi Oka

  • 1Endocrine Disruptors and Dioxin Research Projects, National Institute for Environmental Studies, Tsukuba 305-8506, Japan. ishidou@nies.go.jp

Regulatory Peptides
|December 29, 2004
PubMed

Insights

Exposure to endocrine disruptors like BPA and phthalates caused hyperactivity in rats. These chemicals altered gene expression in brain pathways, impacting neurotransmitter systems.

Area of Science:

  • Environmental toxicology
  • Neuroendocrinology
  • Developmental toxicology

Background:

  • Endocrine disruptors are chemicals that can interfere with the body's endocrine system.
  • Exposure during critical developmental periods may have long-lasting effects on behavior and neurobiology.
  • Specific endocrine disruptors have been linked to various health concerns, but their precise neurobehavioral impacts require further elucidation.

Purpose of the Study:

  • To investigate the behavioral and cellular effects of specific endocrine disruptors in developing male Wistar rats.
  • To determine if early-life exposure to endocrine disruptors leads to altered neurochemical pathways and behavioral changes later in life.

Main Methods:

  • Single intracisternal administration of endocrine disruptors (BPA, p-octylphenol, nonylphenol, DBP, DCHP, DEHP) to 5-day-old rats.
  • Behavioral testing for hyperactivity at 4-5 weeks of age.
  • DNA macroarray analysis of midbrain gene expression at 8 weeks.
  • Immunohistochemical analysis of tyrosine hydroxylase in the substantia nigra.

Main Results:

  • Endocrine disruptor exposure resulted in significant hyperactivity in rats during the nocturnal phase.
  • Gene expression analysis revealed alterations in G protein-coupled receptors involved in dopaminergic and peptidergic neurotransduction.
  • Specific changes included decreased dopamine receptor D1A, increased dopamine receptor D2, and downregulated galanin receptor 2 expression.
  • Dopamine transporter gene expression was significantly decreased by some disruptors.
  • Immunohistochemistry showed impaired tyrosine hydroxylase immunoreactivity in the substantia nigra following p-octylphenol exposure.

Conclusions:

  • Early-life exposure to endocrine disruptors induces hyperactivity in rats.
  • These effects are associated with significant alterations in the gene expression of key neurotransmitter systems, including dopaminergic and peptidergic pathways.
  • Endocrine disruptors likely impact both gene expression and protein levels within these critical neurobiological systems.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...